Zum Hauptinhalt springen
| Hans-Günter Meyer-Thompson | Impfungen

Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study 

Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study 

Noam Barda, Noa Dagan, Cyrille Cohen, Miguel A Hernán, Marc Lipsitch, Isaac S Kohane, Ben Y Reis, Ran D Balicer 

The Lancet, Published online: October 29, 2021 

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)02249-2/fulltext